- Home
- CTMX vs RBOT Comparison
CTMX vs RBOT Comparison
Compare CTMX & RBOT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- RBOT
- Stock Information
- Founded
- CTMX 2008
- RBOT 2014
- Country
- CTMX United States
- RBOT United States
- Employees
- CTMX N/A
- RBOT 131
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- RBOT Medical Specialities
- Sector
- CTMX Health Care
- RBOT Health Care
- Exchange
- CTMX Nasdaq
- RBOT Nasdaq
- Market Cap
- CTMX 62.3M
- RBOT 54.2M
- IPO Year
- CTMX 2015
- RBOT N/A
- Fundamental
- Price
- CTMX $0.59
- RBOT $8.77
- Analyst Decision
- CTMX Buy
- RBOT Hold
- Analyst Count
- CTMX 6
- RBOT 2
- Target Price
- CTMX $5.77
- RBOT $10.25
- AVG Volume (30 Days)
- CTMX 3.5M
- RBOT 49.7K
- Earning Date
- CTMX 03-06-2025
- RBOT 04-28-2025
- Dividend Yield
- CTMX N/A
- RBOT N/A
- EPS Growth
- CTMX N/A
- RBOT N/A
- EPS
- CTMX 0.38
- RBOT N/A
- Revenue
- CTMX $138,103,000.00
- RBOT N/A
- Revenue This Year
- CTMX N/A
- RBOT N/A
- Revenue Next Year
- CTMX N/A
- RBOT N/A
- P/E Ratio
- CTMX $1.56
- RBOT N/A
- Revenue Growth
- CTMX 36.45
- RBOT N/A
- 52 Week Low
- CTMX $0.57
- RBOT $4.27
- 52 Week High
- CTMX $5.85
- RBOT $19.00
- Technical
- Relative Strength Index (RSI)
- CTMX 29.59
- RBOT 35.51
- Support Level
- CTMX $0.60
- RBOT $8.34
- Resistance Level
- CTMX $0.78
- RBOT $10.70
- Average True Range (ATR)
- CTMX 0.06
- RBOT 1.04
- MACD
- CTMX -0.00
- RBOT -0.32
- Stochastic Oscillator
- CTMX 4.17
- RBOT 13.35
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About RBOT Vicarious Surgical Inc.
Vicarious Surgical Inc designs a surgical robot that enables surgeons to perform minimally invasive surgery with 3D visualization and accurate control. Its Vicarious Surgical Robotic System is designed with a focus on abdominal access and visualization through a single port.